Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Merck Serono SA
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono SA, Institut Gustave Roussy (IGR), Institut National de la Sante et de la Recherche Medicale INSERMfiledCriticalMerck Serono SA
Priority claimed from PCT/FR1995/000593external-prioritypatent/WO1995030750A2/en
Publication of AU2570195ApublicationCriticalpatent/AU2570195A/en
Publication of AU708825B2publicationCriticalpatent/AU708825B2/en
Application grantedgrantedCritical
Publication of AU708825CpublicationCriticalpatent/AU708825C/en
Assigned to MERCK SERONO SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT GUSTAVE ROUSSYreassignmentMERCK SERONO SAAlteration of Name(s) in Register under S187Assignors: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., INSTITUT GUSTAVE ROUSSY, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
AU25701/95A1994-05-061995-05-05Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
ExpiredAU708825C
(en)
7alpha-(xi-aminoalkyl)-estrathienes, method of obtaining them, pharmacautic preparations containing such compounds and their application in production of therapeutic agents